In vivo biological response to recombinant interferon-gamma during a phase I dose-response trial in patients with metastatic melanoma.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 2112184)

Published in J Clin Oncol on June 01, 1990

Authors

J M Kirkwood1, M S Ernstoff, T Trautman, G Hebert, Y Nishida, C A Davis, J Balzer, S Reich, J Schindler, S A Rudnick

Author Affiliations

1: Pittsburgh Cancer Institute, Division of Medical Oncology, PA 15213.

Articles by these authors

(truncated to the top 100)

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol (1996) 9.68

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol (1999) 5.95

High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801. J Clin Oncol (2001) 4.84

High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. J Clin Oncol (2000) 4.60

SOME PROPERTIES OF POLIOMYELITIS VIRUS. J Bacteriol (1930) 3.56

The influence of drug interval on the effect of methotrexate and fluorouracil in the treatment of advanced colorectal cancer. J Clin Oncol (1991) 3.36

Six-NB-tropic murine leukemia viruses derived from a B-tropic virus of BALB/c have altered p30. J Virol (1977) 3.27

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology (1987) 3.11

Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2006) 2.77

Evidence for recombination between N- and B-tropic murine leukemia viruses: analysis of three virion proteins by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Virol (1977) 2.49

Distortion of proximodistal information causes JNK-dependent apoptosis in Drosophila wing. Nature (1999) 2.42

Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor. J Clin Oncol (2000) 2.37

Complete sequence of the bithorax complex of Drosophila. Proc Natl Acad Sci U S A (1995) 2.29

Ordering of mouse immunoglobulin heavy chain genes by molecular cloning. Nature (1981) 2.28

Inverted terminal repeat sequence in the macronuclear DNA of Stylonychia pustulata. Gene (1980) 2.28

Evidence for recombination between N- and B-tropic murine leukemia viruses. J Virol (1977) 2.20

Recent skin self-examination and doctor visits in relation to melanoma risk and tumour depth. Br J Dermatol (2012) 2.20

Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease. Antimicrob Agents Chemother (1996) 2.13

Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2006) 2.12

A protein kinase similar to MAP kinase activator acts downstream of the raf kinase in Drosophila. Cell (1993) 2.10

Tissue-shrinkage correction factor in the calculation of prostate cancer volume. Am J Surg Pathol (1996) 2.06

The Subgradient Extragradient Method for Solving Variational Inequalities in Hilbert Space. J Optim Theory Appl (2011) 2.03

Subtle cerebellar phenotype in mice homozygous for a targeted deletion of the En-2 homeobox. Science (1991) 2.01

Legionella moravica sp. nov. and Legionella brunensis sp. nov. isolated from cooling-tower water. Ann Inst Pasteur Microbiol (1988) 1.84

Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. Arch Neurol (2001) 1.84

p38 mitogen-activated protein kinase can be involved in transforming growth factor beta superfamily signal transduction in Drosophila wing morphogenesis. Mol Cell Biol (1999) 1.83

Cloning and expression of a Streptococcus sanguis surface antigen that interacts with a human salivary agglutinin. Infect Immun (1988) 1.75

Clinical implementation of dynamic intensity-modulated radiotherapy: Dosimetric aspects and initial experience. J Med Phys (2008) 1.72

Methicillin-resistant Staphylococcus aureus clonal types in the Czech Republic. J Clin Microbiol (1999) 1.69

Leucine-rich repeats and carboxyl terminus are required for interaction of yeast adenylate cyclase with RAS proteins. Proc Natl Acad Sci U S A (1990) 1.63

Cloning of mouse immunoglobulin epsilon gene and its location within the heavy chain gene cluster. Proc Natl Acad Sci U S A (1981) 1.62

Increased replication of HTLV-I in HTLV-I-associated myelopathy. Ann Neurol (1989) 1.60

Use of IFN-gamma in patients with AIDS. J Acquir Immune Defic Syndr (1990) 1.59

Homozygous deletions within human chromosome band 9p21 in melanoma. Proc Natl Acad Sci U S A (1992) 1.58

Rearrangements of immunoglobulin genes during differentiation and evolution. Immunol Rev (1981) 1.54

Structural markers on core protein p30 of murine leukemia virus: functional correlation with Fv-1 tropism. Proc Natl Acad Sci U S A (1978) 1.51

In vitro and in vivo activation of human mononuclear phagocytes by interferon-gamma. Studies with normal and AIDS monocytes. J Immunol (1987) 1.51

High-dose cisplatin and dacarbazine in the treatment of metastatic melanoma. J Natl Cancer Inst (1990) 1.51

CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathies. Neurology (2003) 1.50

Early postimplantation embryo lethality due to DNA rearrangements in a transgenic mouse strain. Proc Natl Acad Sci U S A (1986) 1.48

Absence of myocardial 123I-BMIPP uptake in the presence of a normal coronary angiogram and normokinetics on a left ventriculogram. Jpn Circ J (1997) 1.48

A cost analysis of postoperative management in endometrial cancer patients treated by robotics versus laparoscopic approach. Gynecol Oncol (2011) 1.47

A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J Immunol Methods (1999) 1.46

A Drosophila MAPKKK, D-MEKK1, mediates stress responses through activation of p38 MAPK. EMBO J (2001) 1.42

Earliest evidence for the use of pottery. Nature (2013) 1.42

Using HL7 and the World Wide Web for unifying patient data from remote databases. Proc AMIA Annu Fall Symp (1996) 1.39

Urinary albumin excretion in short children treated with recombinant human growth hormone. Clin Nephrol (1996) 1.39

Long terminal repeat-like elements flank a human immunoglobulin epsilon pseudogene that lacks introns. EMBO J (1982) 1.39

Ammonia determines the choice of morphogenetic pathways in Dictyostelium discoideum. J Mol Biol (1977) 1.37

Human in vivo antigenic modulation induced by the anti-T cell OKT3 monoclonal antibody. Eur J Immunol (1982) 1.37

CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology (2001) 1.35

The Drosophila RBP-J kappa gene encodes the binding protein for the immunoglobulin J kappa recombination signal sequence. J Biol Chem (1991) 1.34

DNA cleavage by type III restriction-modification enzyme EcoP15I is independent of spacer distance between two head to head oriented recognition sites. J Mol Biol (2001) 1.32

Requirement of voltage-dependent anion channel 2 for pro-apoptotic activity of Bax. Oncogene (2009) 1.32

[Regulation of the glucose-6-phosphate dehydrogenase of different bacterial species by ATP]. Arch Mikrobiol (1969) 1.32

Drosophila proliferating cell nuclear antigen (cyclin) gene: structure, expression during development, and specific binding of homeodomain proteins to its 5'-flanking region. Mol Cell Biol (1990) 1.31

Cloning of human immunoglobulin epsilon chain genes: evidence for multiple C epsilon genes. Proc Natl Acad Sci U S A (1982) 1.30

Carriage of antibiotic-resistant Streptococcus pneumoniae by children in eastern and central Europe--a multicenter study with use of standardized methods. Clin Infect Dis (1996) 1.29

Saliva-mediated aggregation of Enterococcus faecalis transformed with a Streptococcus sanguis gene encoding the SSP-5 surface antigen. Infect Immun (1989) 1.29

Operational criteria for adverse drug reactions in evaluating suspected toxicity of a popular scabicide. Clin Pharmacol Ther (1980) 1.27

cDNA cloning of PG-M, a large chondroitin sulfate proteoglycan expressed during chondrogenesis in chick limb buds. Alternative spliced multiforms of PG-M and their relationships to versican. J Biol Chem (1993) 1.27

Phonon dispersion in graphite. Phys Rev Lett (2004) 1.26

Induction of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2). Biochem Biophys Res Commun (1990) 1.23

In vivo description of dendritic cells in human renal cell carcinoma. J Urol (1999) 1.23

Venous air embolism during hepatic resection. Anesthesiology (1990) 1.23

Involvement of JNK in the regulation of autophagic cell death. Oncogene (2010) 1.22

Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. Autoimmunity (2006) 1.22

Interferons in the treatment of human cancer. J Clin Oncol (1984) 1.22

A novel Drosophila receptor tyrosine kinase expressed specifically in the nervous system. Unique structural features and implication in developmental signaling. J Biol Chem (1997) 1.21

Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody. Proc Natl Acad Sci U S A (2000) 1.20

MRI measurements of normal extraocular muscles and other orbital structures. Graefes Arch Clin Exp Ophthalmol (2000) 1.20

Evaluation of T cell subsets with monoclonal antibodies in patients with rheumatoid arthritis. J Rheumatol (1982) 1.19

Regulation of JNK by Src during Drosophila development. Science (2000) 1.18

Comparison of the gastrointestinal syndrome after total-body or total-abdominal irradiation. Radiat Res (1989) 1.18

De novo synthesis of sphingolipids is required for cell survival by down-regulating c-Jun N-terminal kinase in Drosophila imaginal discs. Mol Cell Biol (1999) 1.18

A hydrogen sulphide producing Gram-negative rod from water. Zentralbl Bakteriol Mikrobiol Hyg A (1983) 1.17

Cardiac dysfunction with Becker muscular dystrophy. Am Heart J (1996) 1.16

A novel Drosophila nuclear protein serine/threonine kinase expressed in the germline during its establishment. Mech Dev (1998) 1.16

Immobilization of Escherichia coli cells containing aspartase activity with kappa-carrageenan. Enzymic properties and application for L-aspartic acid production. Biochim Biophys Acta (1979) 1.15

Prognostic factors in primary gastrointestinal leiomyosarcoma: a retrospective study. World J Surg (1992) 1.15

A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma. Blood (1996) 1.15

Structure and expression during development of Drosophila melanogaster gene for DNA polymerase alpha. Nucleic Acids Res (1991) 1.15

Serum complement levels in infancy: age related changes. Pediatr Res (1979) 1.14

Transcriptional regulation of the Drosophila CycA gene by the DNA replication-related element (DRE) and DRE binding factor (DREF). Nucleic Acids Res (1996) 1.14

Isolation and characterization of mouse mutant embryonal carcinoma cells which fail to differentiate in response to retinoic acid. Proc Natl Acad Sci U S A (1981) 1.14

Partial properdin deficiency. J Lab Clin Med (1980) 1.14

Hyaluronan oligosaccharides perturb cartilage matrix homeostasis and induce chondrocytic chondrolysis. Arthritis Rheum (2000) 1.13

A phase I study of combination therapy with immunotoxins IgG-HD37-deglycosylated ricin A chain (dgA) and IgG-RFB4-dgA (Combotox) in patients with refractory CD19(+), CD22(+) B cell lymphoma. Clin Cancer Res (2000) 1.13

Salivary-agglutinin-mediated adherence of Streptococcus mutans to early plaque bacteria. Infect Immun (1991) 1.12

Missense and nonsense mutations in the lysosomal alpha-mannosidase gene (MANB) in severe and mild forms of alpha-mannosidosis. Am J Hum Genet (1998) 1.11

Ex vivo expansion of non-MHC-restricted cytotoxic effector cells as adoptive immunotherapy for myeloma. Cytotherapy (2006) 1.11

Maximum androgen blockade in advanced prostate cancer: a meta-analysis of published randomized controlled trials using nonsteroidal antiandrogens. Urology (1997) 1.08

A gene family in Drosophila melanogaster coding for trypsin-like enzymes. Nucleic Acids Res (1985) 1.08

Analysis of the function of the 70-kilodalton cyclase-associated protein (CAP) by using mutants of yeast adenylyl cyclase defective in CAP binding. Mol Cell Biol (1993) 1.07

Determination of T lymphocyte subpopulations by monoclonal antibodies in rheumatoid arthritis. Influence of immunomodulating agents. Int J Immunopharmacol (1981) 1.06

Structure of the human immunoglobulin C epsilon 2 gene, a truncated pseudogene: implications for its evolutionary origin. Proc Natl Acad Sci U S A (1983) 1.06

Ultrasensitive nanoparticle detection using a portable whispering gallery mode biosensor driven by a periodically poled lithium-niobate frequency doubled distributed feedback laser. Rev Sci Instrum (2010) 1.06

Alternative cell fate choice induced by low-level expression of a regulator of protein phosphatase 2A in the Drosophila peripheral nervous system. Development (1994) 1.06

Investigations into the fat pads of the sole of the foot: anatomy and histology. Foot Ankle (1992) 1.05

Promoter CpG methylation in cancer cells contributes to the regulation of MUC4. Br J Cancer (2009) 1.05